Affiliation:
1. Bashkir State Medical University
2. Bashkir State Medical University;
Republican Clinical Oncology Dispensary
3. Bashkir State Medical University;
Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences
Abstract
Background. Cervical cancer is among the commonest malignancies and a top fourth leading cause of cancer death in women worldwide. The five-year survival rate in locally advanced cervical cancer is 91.5%, and only 17.2% — in distant metastasis. Primary cervical cancer metastasis to brain is very rare. Report and analysis of quite rare clinical cases may shed light on this issue, helping formulate relevant therapeutic and diagnostic interventions.Materials and methods. The article describes a case of cervical cancer metastasis to brain. The patient received modern 3D conformal intensity-modulated (IMRT) and image-guided (IGRT) radiation therapies on an Elekta Synergy highenergy linear digital accelerator instrument.Results. Clinical effect has been achieved by end of treatment. Time since diagnosis of primary cervical cancer was 13 months, and 7 months — since diagnosis of brain metastasis.Discussion. The survival rate in brain metastasis is marginal-low and depends on the patient’s age, primary tumour state, presence of extracranial metastases, as well as volume, number and location of metastases in brain parenchyma. An integrated approach including surgery, radiation and chemotherapy is considered superior to improve survival and the quality of life.Conclusion. Despite sheer coverage of therapies available, the mean survival rate in intracranial metastasis remains subtle. Thereby, research and discovery of relapse and metastasis biomarkers of cervical cancer is relevant.
Publisher
Bashkir State Medical University
Subject
General Engineering,Energy Engineering and Power Technology
Reference14 articles.
1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. DOI: 10.3322/caac.21492
2. Howlader N., Krapcho M., Miller D., Brest A., Yu M., Ruhl J., et al. SEER Cancer Statistics Review, 1975–2017. Bethesda: National Cancer Institute; 2020.
3. Global strategy to accelerate the elimination of cervical cancer as a public health problem. WHO; 2020. 4 Surveillance, epidemiology end results program. Cancer Stat Facts: Cervical Cancer; National Cancer Institute. [cited 2020 Dec 20]. Available online: https://seer.cancer.gov/statfacts/html/cervix.html
4. Li H., Wu X., Cheng X. Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol. 2016;27(4):e43. DOI: 10.3802/jgo.2016.27.e43
5. Divine L.M., Kizer N.T., Hagemann A.R., Pittman M.E., Chen L., Powell M.A., et al. Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain. Gynecol Oncol. 2016;142(1):76–82. DOI: 10.1016/j.ygyno.2016.04.030